Drug Search Results
More Filters [+]

Ergotamine

Alternative Names: ergotamine, ergomar, ergostat, wigrettes, ergomar sublingual, cafergot, migergot, wigraine
Latest Update: 2017-01-18
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT2 Agonist,ADRA1A Agonist,ADRA1B Agonist,ADRA1D Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Bangladesh | Belgium | Bosnia | Brazil | Canada | Chile | Dominican Republic | Ecuador | Egypt | France | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Jordan | Korea | Malaysia | Malta | Mexico | Morocco | New Zealand | Pakistan | Peru | Poland | Portugal | Russia | Serbia | Singapore | Slovenia | Spain | Sweden | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ergotamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title